Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc)

Specifications

Catalog number

PKSH034025-01

Size / count

10 µg

Dry ice

No

Hazardous

No

Discontinued

No

Background

Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.

Abbreviation

Butyrophilin-like9; BTNL9

Synonyms

BTNL9; Butyrophilin-like protein 9

UniProt

Q6UXG8

Accession Number

Q6UXG8

Expression System

HEK293 Cells

Tag

C-Fc

Sequence

Ser35–Lys256

Endotoxin

< 1.0 EU per μg of the protein as determined by the LAL method.

Purity

> 95 % as determined by reducing SDS-PAGE.

Bioactivity

Not validated for activity

Reconstitution

Please refer to the printed manual for detailed information.

Shipping Conditions

This product is provided as lyophilized powder which is shipped with ice packs.

Storage Conditions

Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Calculated Molecular Weight

52.0 kDa

Observed Molecular Weight

55-70 kDa

Species

Human